Researchers compared patients taking GLP-1 drugs including semaglutide, sold under the brand names Ozempic and Wegovy, and liraglutide, sold as Victoza and Saxenda to patients not taking them
In that study a random sample of over 15 million people taking prescription medication showed that GLP-1 agonists cause increased risk of bowel obstruction and gastroparesis
A network meta-analysis comparing cardiovascular outcomes and mortality by GLP1-RA showed the following outcomes: MACE, cardiovascular death, death from any cause, myocardial infarction, stroke, and heart failure hospitalization 17
Patients from ethnic minority backgrounds, including Black African, South Asian, and Middle Eastern, are eligible at a lower BMI due to higher health risks
This applies for resting voltage (ie, after you take the lipo out of the RC and head home and check on your charger) and transient voltage from voltage sag during load
Did you know that women over 40 make up the largest group of GLP-1 medication users